Add text here
Add text here
|
Organization
|
Category
|
Country
|
Description
|
|
Infectious Disease Testing Laboratories, Performing COVID-19 Tests
|
|||
|
Advanced Laboratory Testing
|
Testing
|
Ireland
|
Assisting government laboratories with their COVID-19 testing.
|
|
Africa Health Research Institute
|
Testing
|
South Africa
|
Performing COVID-19 surveillance studies.
|
|
CAPRISA
|
Testing
|
South Africa
|
Performing COVID-19 surveillance studies.
|
| hVIVO | Testing | UK | hVIVO COVID Clear Test is the most accurate antibody test available to employers in the UK and Ireland, helping them to get their people back to work. |
|
Instituto Butantan
|
Testing & Vaccine
|
Brazil
|
Instituto Butantan supplies the Brazilian public health system with 90% of the antivenin and 65% of all vaccines distributed in the country. Out of the 170 million doses of vaccines dispensed annually by the Brazilian immunization program, 100 million are produced by Butantan. In particular, Instituto Butantan manufactures 100% of the influenza vaccine doses used by the Ministry of Health. Presently, we are the largest flu vaccine manufacturer in the Southern Hemisphere. Butantan is already processing COVID samples and is going to coordinate a network of 38 Laboratories in the Sao Paulo area.
|
|
Los Alamos
|
Testing
|
USA
|
Testing for the State of New Mexico.
Los Alamos National Laboratory, like many of the Department of Energy National Laboratories, is drawing on it's rich history in the biological sciences to actively engage in the national effort to study, understand, and answer important questions about the COVID-19 outbreak. Areas covered include disease detection and diagnostics, epidemic modeling, disease prediction and forecasting, decision support, data collection and integration, and medical measures. |
|
MOH Kenya
|
Testing
|
Kenya
|
|
|
National Public Health Laboratory Services (NPHLS) Kenya
|
Testing
|
Kenya
|
|
|
NIH NIAID
|
NIAID scientists and grantees are well positioned to rapidly develop COVID-19 diagnostics, therapeutics and vaccines. These projects include conducting basic research to understand how the virus infects cells and causes disease, and what interventions can prevent and stop the spread of disease. In fact, within two weeks of the discovery of COVID-19, NIAID researchers had determined how the virus enters cells. And within two months sites had begun Phase 1 trials of a treatment (Remdesivir) and a vaccine (mRNA-1273).
|
||
|
Ortho Clinical Diagnostics
|
Testing
|
USA
|
Ortho’s Total Antibody Test for COVID-19 receives Emergency Use Authorization from FDA. This test is one of the first high-throughput, automated COVID-19 antibody tests to be granted Emergency Use Authorization.
|
|
Pangaea
|
Testing
|
Spain
|
Developing diagnostic.
|
| Province of Manitoba | Testing | Canada | |
|
Province of Ontario
|
Testing
|
Canada
|
Since the outset, Public Health Ontario has been conducting laboratory testing and working with healthcare partners to expand testing capacity. We have also been working very closely with the Ministry of Health and local public health units to provide evidence and expertise to inform decisions and policy around surveillance, case and contact management, and infection control.
|
|
Province of Saskatchewan
|
Testing
|
Canada
|
|
| Public Health Agency of Canada – National Microbiology Laboratory | Testing | Canada | Canada's National Microbiology Laboratory is performing diagnostic testing for the virus that causes COVID-19. The laboratory is working in close collaboration with provincial and territorial public health laboratories. |
|
Randox
|
Testing
|
UK
|
Randox has developed a rapid test for COVID-19 (SARS-CoV-2), the new strain of Coronavirus.
|
|
Royal College of Pathologist of Australasia Quality Assurance Program
|
Testing
|
Australia
|
In response to requests from laboratories and from the Australian Government’s Department of Health, and in line with the Enhancing Laboratory Capacity and Capability contract RCPAQAP has with the Department of Health, RCPAQAP Biosecurity will be offering a proficiency testing program (PTP) for the 2019-novel coronavirus, SARS-CoV-2. This will assist with the response to the outbreak of COVID-19, a respiratory illness caused by a novel coronavirus first identified in Wuhan, Hubei Province and recently declared a Public Health Emergency of International Concern by the WHO.
RCPAQAP Biosecurity have organized for two rounds of a PHLN Module: SARS-CoV-2 and other coronaviruses. Round 1 was offered to a select number of laboratories however, Round 2 is to be offered to both public and private Australian laboratories free of charge in this instance, with the support of the Department of Health, in recognition of the extraordinary circumstances of the SARS-CoV-2 outbreak. |
| Scottish Environment Protection Agency (SEPA) | Testing | UK | At the Scottish Environment Protection Agency (SEPA) we are working with our partner agencies to sample sewage influents for analysis in our Microbiology/Genomics lab for the presence of COVID-19 RNA. This data will be used to assist in tracking the geographical spread of the virus in Scotland. LabWare is at the core of this work and is being used to plan and schedule the sampling activities, streamline the laboratory working processes, collect result data and provide reporting data sets for our GIS-based reporting tools. |
|
Siemens Healthcare Diagnostics
|
Testing
|
USA
|
|
|
South African Medical Research Council HIV Prevention Research Unit (HPRU)
|
Testing
|
South Africa
|
Performing COVID-19 surveillance studies.
|
| State of Delaware, Public Health Laboratory | Testing | USA | |
| State of Florida, Bureau of Public Health | Testing | USA | |
|
Texas Department Of State Health Services Public Health Laboratory
|
Testing
|
USA
|
|
|
State of New Mexico, Scientific Laboratory
|
Testing
|
USA
|
|
|
Utah Public Health Laboratory
|
Testing
|
USA
|
|
|
State of Oklahoma, Public Health Laboratory
|
Testing
|
USA
|
|
|
South Dakota State Public Health Laboratory
|
Testing
|
USA
|
|
|
Pharmaceutical Companies Developing a COVID-19 Vaccine or Treatment
|
|||
|
APB Association Pharmacy
|
Treatment
|
Belgium
|
Branch organisation for pharmacists. Takes care of informing pharmacists and answers questions from pharmacists about COVID-19.
|
|
Apotex
|
Treatment
|
Canada
|
Producing a drug for a clinical trial.
|
|
Ardena Biochemical Laboratory BV
|
Treatment
|
Netherlands
|
In the worldwide battle against the Coronavirus, many clinical studies are being initiated to test the efficacy of Chloroquine and Hydroxychloroquine, two existing anti-malaria therapeutics. In support of this important and urgent global endeavor, our bioanalytical team has developed LC-MS/MS methods for the quantification of both compounds in human plasma.
|
| AstraZeneca | Treatment | UK |
|
|
Bayer
|
Treatment
|
Germany
|
Product Resochin (originally used to fight against Malaria) into countries like China, Italy and USA - it contains Chloroquine, that has been found in some situations to be helpful for COVID infected patients to get healthy again.
|
|
BioNTech
|
Vaccine
|
Germany
|
Anti-viral compounds show activity against SARS-CoV-2 in preclinical screening. Pfizer and BioNTech enter into collaboration agreement to co-develop potential COVID-19 vaccine. Company shares additional data and analysis of Azithromycin. Launch of two new studies to provide insights on the interaction between S. pneumoniae and SARS-CoV-2. Pfizer explores studies of JAK inhibitor tofacitinib in patients with COVID-19-related pneumonia.
|
|
Boehringer Ingelheim Pharma GmbH & Co. KG
|
|
||
|
CSL Behring GmbH
|
Treatment
|
Germany
|
Pharmaceutical company with a focus on rare diseases. Member of the CoVIg-19 Plasma Alliance.
|
|
CSL Plasma
|
Treatment
|
Germany
|
Pharmaceutical company with a focus on human plasma. Member of the CoVIg-19 Plasma Alliance.
|
| Cipla | Testing | India |
|
|
Fresenius Kabi Deutschland GmbH
|
Treatment
|
Germany
|
One of the world's largest pharmaceutical companies. Fresenius Kabi takes comprehensive measures to increase supply of essential drugs during the COVID-19 pandemic.
|
|
GBA PHARMA GmbH
|
Testing
|
Germany
|
GBA Group Pharma is one of Europe’s largest and most experienced service providers for the pharmaceutical and biotech sector.
|
| Gilead | Treatment | USA | Using investigational medicine Remdesivir on a small group of patients with severe symptoms of COVID-19. |
|
GlaxoSmithKline
|
Vaccine
|
UK
|
|
|
HSE Public Health Services Executive - Ireland
|
Testing
|
Ireland
|
The Health Services Executive is responsible for the provision of health and personal social services for everyone living in Ireland. Has initiated and setup specific COVID-19 testing services.
|
| Incyte | Treatment | USA | On April 17, 2020, we announced the initiation of RUXCOVID, a global, randomized, double-blind, placebo-controlled Phase 3 clinical trial evaluating the efficacy and safety of Ruxolitinib (Jakafi®) plus standard-of-care (SoC) in patients aged ≥12 years with COVID-19 associated cytokine storm. The collaborative study is sponsored by Incyte in the United States and Novartis outside of the United States. |
|
Instituto Butantan - Brazil / Sao Paulo
|
Testing
|
Brazil
|
Instituto Butantan supplies the Brazilian public health system with 90% of the antivenin and 65% of all vaccines distributed in the country. Out of the 170 million doses of vaccines dispensed annually by the Brazilian immunization program, 100 million are produced by Butantan. In particular, Instituto Butantan manufactures 100% of the influenza vaccine doses used by the Ministry of Health. Presently, we are the largest flu vaccine manufacturer in the Southern Hemisphere. Butantan is already processing COVID samples and is going to coordinate a network of 38 laboratories in the Sao Paulo area.
|
|
Janssen Vaccines (J&J)
|
Vaccine
|
Netherlands
|
|
| Oxford BioMedica | Treatment | UK | Cancer and Parkinsons treatment, working with Oxford's Jenner Institute to support the testing and potential production of COVID-19 vaccine. |
|
Pfizer
|
Vaccine
|
UK
|
Anti-viral compounds show activity against SARS-CoV-2 in preclinical screening. Pfizer and BioNTech enter into collaboration agreement to co-develop potential COVID-19 vaccine. Company shares additional data and analysis of Azithromycin. Launch of two new studies to provide insights on the interaction between S. pneumoniae and SARS-CoV-2. Pfizer explores studies of JAK inhibitor tofacitinib in patients with COVID-19 related pneumonia.
|
|
Pfizer
|
Vaccine | USA | Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the first participants have been dosed in the U.S. in the Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19. The trial is part of a global development program, and the dosing of the first cohort in Germany was completed. The Phase 1/2 study is designed to determine the safety, immunogenicity and optimal dose level of four mRNA vaccine candidates evaluated in a single, continuous study. |
|
Pharmascience
|
Treatment
|
Canada
|
Producing a drug for a clinical trial.
|
| Quotient BioSciences | Vaccine | UK | Has announced a collaboration with CytoAgents Inc to accelerate the development of a lead COVID-19 drug candidate into human clinical trials. |
|
Regeneron
|
Treatment
|
USA
|
Based on recent clinical data from studies in China with another IL-6 inhibitor, we believe there is a potential role for Kevzara® (Sarilumab) in the treatment of severe and critical hospitalized patients with COVID-19. Together with our collaborators at Sanofi, we are conducting controlled clinical studies to evaluate Kevzara in this setting.
|
| STADA Arzneimittel AG | Treatment | Germany | STADA is a leading manufacturer of high-quality pharmaceuticals with a focus on generics, including specialty pharmaceuticals and non-prescription consumer healthcare products. |
|
Sanofi
|
Vaccine
|
France
|
|
| TRON – Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz gemeinnützige GmbH | Vaccine | Germany | University spin-off. Innovative immunological research institute. TRON was asked by a renowned industrial partner to support the development of a vaccine against the currently pandemic Coronavirus with preclinical studies. |
|
Takara Bio
|
Treatment
|
Japan
|
The Chinese Center for Disease Control and Prevention recommended Takara Bio's One Step PrimeScript RT-PCR Kit (Perfect Real Time) for the detection of the novel Coronavirus.
|
|
Teva
|
Treatment
|
Israel
|
Donated treatment. Recently this effort included enabling tablets and API manufactured in our Goa, India plant to be retrieved in a timely way so to be able to expand access to the medicine globally.
|
|
Viroclinics Biosciences BV
|
Treatment
|
Netherlands
|
International partnership progresses UQ COVID-19 project.
|
|
Other Public Health Laboratories
|
|||
| AMREF | Testing | Kenya | |
|
ARPA Veneto
|
Testing
|
Italy
|
Laboratory performs testing on food and drinking water for the Ministry of Health.
|
| Aahus University, Department of Forensic Medicine | Testing | Denmark | Analyzing Forensic Chemistry samples, Aarhus, Denmark. |
|
AsureQuality Limited
|
Testing
|
New Zealand
|
AsureQuality provides food assurance and biosecurity services to the food and primary production sectors worldwide. Wholly owned by the New Zealand Government, AsureQuality has built a solid reputation for delivering expert services and value to the entire food supply chain. Every day their team of 1800 experts, based at locations throughout Australasia and Southeast Asia, work alongside customers in over 40 countries worldwide, to assure the safety and quality of food being produced for millions of people.
|
|
BST
|
Biobank
|
Spain
|
|
|
Biobank West
|
Biobank
|
Sweden
|
Collaboration between Region Västra Götaland and Sahlgrenska Academy at University of Gothenburg, collecting, storing and managing regional biobank samples - currently prioritizing studies related to COVID-19.
|
| Biocon Limited | India | Biocon is responding to the COVID-19 outbreak, consistent with it's belief that the pharmaceuticals industry has a humanitarian responsibility to serve patients who are in need. Our people across various functions are committed to ensure the continuity of the production and supply of our life-saving medicines and we are committed to ensure their personal health and safety. | |
|
Burundi Ministry of Health
|
Testing
|
Burundi
|
|
|
CAIB
|
Testing
|
Spain
|
Public Health Laboratory Services.
|
| CNTA | Testing | Spain | National food testing organization. |
| CityU Veterinary Diagnostic Laboratory Company Limited | Testing | Hong Kong | The mission of the CityU Veterinary Diagnostic Laboratory (CityU VDL) is to provide a comprehensive veterinary diagnostic service to the veterinarians and researchers of Hong Kong. The CityU VDL is also in a unique position to offer support into animal disease research. |
|
Copenhagen University, Department of Forensic Medicine
|
Testing
|
Denmark
|
Analyzing Forensic Genetics samples. Copenhagen, Denmark.
|
| DNAlysis Biotechnology | Testing | South Africa | |
| Dr Reddy's Laboratories | India | Engaged in various initiatives to contain and cope with the global spread of COVID-19:
|
|
|
Dairy Farmers of America
|
Testing
|
USA
|
|
|
Defence Reference Laboratory
|
Testing
|
Nigeria
|
|
| Deutsches Rotes Kreutz - Blutspendedienst West | Biobank | Germany | German Red Cross - blood bank and blood testing facility for Western Germany. |
| East of Scotland Regional Health Authority | Testing | UK | Provides genetics screening service for the Grampian region. Providing COVID-19 testing support within the Tayside region. |
|
East of Scotland Regional Hospital
|
Testing
|
UK
|
Provides genetics screening service for the Grampion region. Providing COVID-19 testing support within the Tayside region.
|
|
Eufets GmbH
|
Pharmaceutical
|
Germany
|
Contract development and manufacturing organisation specialized in the industrialization of cell and gene therapy products such as viral vectors, cellular products and in vitro transcribed mRNA.
|
|
Forensic Science South Australia / South Australia Police
|
Testing
|
Australia
|
Government forensic testing for the State of South Australia, Australia.
|
|
Genomed
|
Biobank
|
Portugal
|
Molecular medicine diagnostics.
|
|
Grünenthal GmbH
|
Pharmaceutical
|
Germany
|
Privately held pharmaceutical company, global leader in pain management and related diseases.
|
| HIV Pathogenesis Programme (HPP); Nelson R. Mandela School of Medicine | Testing | South Africa | |
| Health Canada – Biologics and Genetic Therapies Directorate | Testing | Canada | |
| Health Canada – Clinical Trial-Adverse Drug reaction | Testing | Canada | |
|
Health Canada – Drug Analysis Service
|
Testing
|
Canada
|
|
|
Health Canada – Health Products and Food Branch Inspectorate
|
Testing
|
Canada
|
|
|
Health Canada – Radiation Protection Bureau
|
Testing
|
Canada
|
|
| Hologic | Testing | UK | Are providing SAR-CoV-2 assay using the industry leading installed base of Hologic's Panther instrument. |
|
ICA - Colombia / National
|
Testing
|
Colombia
|
|
| INC - Colombia / Bogota - Cancer Institute of Cancerology | Biobank | Colombia | |
| Institute de Medicina Molecular | Biobank | Portugal | |
|
KI Biobank
|
Biobank
|
Sweden
|
The biobank provide services for collection, handling, storage and traceability of biobank samples both within and outside of Karolinska Institutet.
|
|
Karolinska University Hospital
|
Testing
|
Sweden
|
The hospital lab uses LabWare for newborn screening analyses and for doping testing.
|
|
Kenya Ministry of Health – AMREF
|
Testing
|
Kenya
|
|
| Kenyatta Hospital | Testing | Kenya | |
| LGC Group | Contract Research Organisation | UK |
|
|
LKF-Laboratorium für Klinische Forschung GmbH
|
Pharmaceutical
|
Germany
|
Member of the GBA group, focused on clinical trials. Specialized medical laboratory unit dedicated exclusively to supporting clinical trials of phases I – IV.
|
|
Lanagro - Brazil / National
|
Testing
|
Brazil
|
|
| Livestock Improvement Corporation | Testing | New Zealand | New Zealand multinational farmer-owned co-operative which, for more than 100 years, has provided genetics expertise, information and technology to the dairy sector, aimed at improving the prosperity and productivity of farmers. |
| Lund University | Testing | Sweden | Sequencing and NGS facility at the Division of Oncology and Pathology. |
| Lupin Limited | Pharmaceutical | India |
|
|
Marsabit Referral Hospital
|
Testing
|
Kenya
|
|
| Medical Research Council | Testing | Uganda | |
|
MEDLASS
|
Testing
|
Kenya
|
|
| Mildmay- Kampala | Testing | Uganda | |
| Ministry of Agriculture | Testing | Brazil | The General Coordination of Agricultural Laboratories - CGAL - is the body of the Ministry of Agriculture, Livestock and Supply - MAPA - competent to manage and organize the laboratory activities of the Secretariat of Agricultural Defense. Together with the six national agricultural laboratories - Lanagros, CGAL constitutes the LANAGRO NETWORK. The work performed by this network plays a fundamental role in the control and supervision of food, beverages and agricultural inputs produced in Brazil and marketed in the country and abroad. It also has strategic action in the sanitary monitoring of herds and crops, participating in the guarantee of the sanitary status of the country and the control and sanitation of animal diseases and plant pests. MAPA will provide installed capacity, infrastructure, and technical teams from their laboratories to assist in Coronavirus testing analysis. |
| Ministry of Health (APHL) | Testing | Kenya | |
| Ministry of Health - East Africa Public Health Laboratory Network (EAPHLN) | Testing | Kenya | |
| Moi Teaching & Referral Hospital | Testing | Kenya | |
| MyLan India | Pharmaceutical | India | |
| NSF | Contract Lab | USA | Independent, not-for-profit, non-governmental public health and safety organization. They helped:
|
| NSW Office of Environment & Heritage | Testing | Australia | Government soil and water testing. |
| Nairobi Hospital | Testing | Kenya | |
|
Nanofarmacia
|
Testing
|
Mexico
|
|
|
National Center for Global Health and Medicine
|
Testing
|
Japan
|
Nationally owned research organization that pursues both experimental and transitional research for infectious diseases and others, contributing to global health and medicine.
|
|
National Institute for Environmental Studies
|
Testing
|
Japan
|
Nationally owned research organization that researches global environmental issues, environmental risks such as chemical substances, environmental issues in developing countries etc., and monitors/observes elucidation and countermeasures of environmental problems.
|
| New Zealand Ministry for Primary Industries | Testing | New Zealand | NZMPI is the public service department of New Zealand charged with overseeing, managing and regulating the farming, fishing, food, animal welfare, biosecurity, and forestry sectors of New Zealand's primary industries. |
| North of Scotland Regional Hospital - Genetics Service | Testing | Scotland | Provides genetics screening service for the Grampion region. |
|
Northern Territory Department of Primary Industry and Fisheries
|
Testing
|
Australia
|
Government testing in agriculture, biosecurity, fisheries, earth resources, energy and forestry policy and programs in the Northern Territory, Australia.
|
|
Odense University, Department of Forensic Medicine
|
Testing
|
Denmark
|
Analyzing forensic medicine samples. Odense, Denmark.
|
| PathWest Laboratory Medicine WA | Testing | Australia | Government food and water testing laboratories. |
|
Pirbright Institute
|
Research
|
UK
|
Research infectious disease in farm animals, are not directly involved with COVID-19 testing as yet.
|
|
Public Health Agency of Canada – Laboratory for Foodborne Zoonoses
|
Testing
|
Canada
|
|
|
Queensland Racing Science Center
|
Testing
|
Australia
|
Government testing for horse and greyhound racing industry.
|
|
Region Zealand
|
Biobank
|
Denmark
|
Collection and storage of biological material - have also a new specific workflow for receiving corona virus samples in their regional LabWare Biobank. Two sites (Næstved and Roskilde), Denmark.
|
|
Rwanda MOH
|
Testing
|
Rwanda
|
|
|
Rwanda National Reference Laboratory
|
Testing
|
Rwanda
|
|
|
Shanghai Institute of Food and Drug Control
|
Testing
|
China
|
Government testing in food and drugs.
|
| Singapore Health Sciences Authority | Testing | Singapore | Government laboratories covering Forensic Chemistry and Physic Laboratory (Crime Unit, Documentation Unit), Illicit Drug Laboratory, Analytical Toxicology Laboratory (Drug Abuse Testing Unit, Clinical and Forensic Toxicology Unit), DNA Profiling Laboratory, Pharmaceutical Laboratory, Cosmetics Laboratory, Cigarette Testing Laboratory, Food Safety Laboratory (Food Testing Unit, Water Testing Unit). |
| Singapore Ministry of Home Affairs | Testing | Singapore | Government forensic testing. |
| Singapore Police Force | Testing | Singapore | Government forensic testing. |
| South African Medical Research Council – Genomics Centre | Testing | South Africa | |
|
South African Medical Research Council HIV Prevention Research Unit (HPRU)
|
Testing
|
South Africa
|
|
|
South African Tuberculosis Vaccine Initiative (SATVI)
|
Testing
|
South Africa
|
|
| South-Eastern Norway Regional Health Authority | Biobank | Norway | Collection and storage of biological material - also recording COVID-19 biobank samples in LabWare. Oslo, Norway. |
| Stockholm Medical Biobank | Biobank | Sweden | Regional Biobank responsible for biobanking of all health care samples in the Stockholm region - they are at this moment prioritizing studies related to COVID-19. |
| Swedish Liquid Based Cytology Biobanks | Biobank | Sweden | Several Swedish hospitals and Universities are using LabWare for biobanking of Liquid Based Cytology samples, 7 sites in different cities: Stockholm, Gothenburg, Umeå, Örebro, Lund, Kalmar, Linköping. |
| Swedish Medical Product Agency | Testing | Sweden | The national authority responsible for regulation and surveillance of the development, manufacturing and sale of pharmaceuticals and other medicinal product in Sweden. During the COVID-19 outbreak, the agency works with regulatory authorities in the EU and the European Medicines Agency (EMA) to support rapid development of treatments and vaccines as well as ensuring access to medicines. Uppsala, Sweden. |
| The Cancer Council Victoria | Testing | Australia | Biobank assisting in cancer research and prevention. |
| The Capital Region of Denmark, Department of Clinical Immunology | Biobank | Denmark | Department of Clinical Immunology, Patient Biobank, Tissue Typing Laboratory - A research team from Department of Clinical Immunology has developed an antibody test that can tell whether patients have developed COVID-19 antibodies after being infected, and they have been setting up a COVID-19 Biobank for patients (Coronavirus samples) and three sites in Copenhagen area, Denmark. |
|
The South African AIDS Vaccine Initiative (SAAVI)
|
Testing
|
South Africa
|
|
|
The Region of Southern Denmark, Department of Clinical Genetics
|
Testing
|
Denmark
|
The Clinical Genetic Department handles genetic counseling and laboratory work. Two sites (Odense and Vejle), Denmark.
|
| USDA | Testing | USA | U.S. Secretary of Agriculture Sonny Perdue today announced the Coronavirus Food Assistance Program (CFAP). This new U.S. Department of Agriculture (USDA) program will take several actions to assist farmers, ranchers, and consumers in response to the COVID-19 national emergency. |
|
Uppsala Biobank
|
Biobank
|
Sweden
|
Regional Biobank responsible for storing biobanking of all health care samples in the Uppsala region, and also collecting samples from Uppsala University - currently prioritizing studies related to COVID-19.
|
| VIDO/InterVac - Vaccine and Infectious Disease Organization - International Vaccine Center | Vaccine | Canada | |
|
Victorian Clinical Genetic Services
|
Testing
|
Australia
|
A wholly owned subsidiary of the Murdoch Children's Research Institute (MCRI) with expertise in cytogenetics, molecular genetics, biochemical genetics, mitochondrial genetics and tissue culture.
|
|
Victorian Clinical Genetic Services - Newborn Screening
|
Testing
|
Australia
|
A wholly owned subsidiary of the Murdoch Children's Research Institute (MCRI) with expertise in newborn screening.
|
|
Victorian Department of Primary Industries
|
Testing
|
Australia
|
Government testing in agriculture, biosecurity, fisheries, earth resources, energy and forestry policy and programs in the State of Victoria, Australia.
|
|
Water Testing
|
|||
| Agbar (Barcelona Water) | Testing | Spain | |
| Aqualia (several towns) | Testing | Spain | |
|
Bay of Plenty Regional Council
|
Testing
|
New Zealand
|
Government water utility testing.
|
| CABB (Bilbao Water) | Testing | Spain | |
| CYII (Madrid Water) | Testing | Spain | |
|
Cairns Regional Council
|
Testing
|
Australia
|
Government water utility testing.
|
|
Cawthron Institute
|
Testing
|
New Zealand
|
Government testing in aquaculture research, marine and freshwater resource management, food safety and quality, algal technologies, biosecurity and analytical testing.
|
| EPA | Testing | Spain | |
| Emasa (Malaga Water) | Testing | Spain | |
| Emasesa (Seville Water) | Testing | Spain | |
| Emuasa (Murcia Water) | Testing | Spain | |
| KWR | Testing | Netherlands | Water research lab COVID-19 sewage research. |
| Labaqua | Contract Lab | Spain | |
|
Seqwater
|
Testing
|
Australia
|
Government water utility testing.
|
|
South Australian Water - Australian Water Quality Center
|
Testing
|
Australia
|
Government water utility testing.
|
|
Stockholm Vatten och Avfall
|
Testing
|
Sweden
|
|
|
Sydney Water Corporation
|
Testing
|
Australia
|
Government water utility testing.
|
|
Tasmania Department of Primary Industries, Parks Water and Environment
|
Testing
|
Australia
|
Government laboratory responsible for supporting primary industry development, the protection of Tasmania's natural environment, effective land and water management and the protection of Tasmania's relative disease and pest free status.
|
| WLN | Testing | Netherlands | Independent partner in research and advice for drinking, industrial and waste water. |
|
Watercare Services Limited
|
Testing
|
New Zealand
|
Government water utility testing.
|
Desde mediados de febrero LabWare ha estado trabajando activamente con organizaciones de los sectores público y privado de todo el mundo para aplicar nuestros considerables conocimientos y tecnología avanzada para implementar la capacidad de pruebas de COVID-19, así como otras mejoras en el flujo de trabajo y la eficiencia operativa para aumentar la capacidad de pruebas de los laboratorios y así satisfacer las demandas de pruebas de salud pública sin precedentes.
Nuestros esfuerzos incluyen la asistencia en los esfuerzos para ampliar las operaciones de pruebas de COVID-19 del NHS en el Reino Unido; el suministro de software de gestión de laboratorio para un nuevo laboratorio de COVID-19 en Sao Paulo, Brasil; la asistencia a los clientes de salud pública de EE. UU. para implementar nuevas pruebas de COVID-19 y protocolos de comunicación para informar a los CDC; la adición/ampliación de las capacidades de pruebas de COVID-19 en toda nuestra base de clientes de salud pública en el África subsahariana, y la asistencia a los clientes de salud pública canadienses con mejoras de rendimiento para manejar el aumento de las pruebas de COVID-19.
Estamos desarrollando soluciones que aprovechan la tecnología Mobile de LabWare para agilizar el proceso de registro de pacientes y de recogida de muestras de COVID-19 como parte de las operaciones de recogida de muestras sobre el terreno y de pruebas de COVID-19. Estas soluciones se están desplegando en nuestros clientes del laboratorio de salud pública estatal.
LabWare se propuso resolver este problema introduciendo un sistema que utiliza dispositivos de tabletas que están atados a un hotspot Mobile y que ejecutan nuestra aplicación para comunicarse con un servidor basado en la nube que cumple con la HIPAA y que ejecuta nuestro LIMS. El sistema permite programar las visitas de los pacientes a los lugares donde se realizan las pruebas, capturando la información demográfica de los pacientes y las respuestas a las numerosas preguntas de triage. En el campo, cuando se recogen las muestras, se imprimen etiquetas que tienen un código de barras, así como el nombre del paciente y el DOB.
Esta información es utilizada por los laboratorios del DOH para identificar la muestra y el paciente. Todos los datos que estamos recogiendo se transmiten en minutos al sistema del DOH, así que cuando las muestras llegan al laboratorio, son escaneadas y están listas para ser analizadas. Inicialmente probamos este sistema en Florida a principios de abril. El plan era reunir información sobre las lagunas en las que necesitamos mejorar el sistema para que esté listo para su uso en vivo.
Para nuestra sorpresa, lo que habíamos hecho satisfacía las necesidades del Departamento de Salud. Planeamos salir de Florida, pero nos dijeron que quieren ir a vivir con el sistema de inmediato. Así que nos quedamos en Florida, y se fueron a vivir la semana siguiente. El Departamento de Salud de Florida se ha comprometido a comprar 303 equipos, suficientes para que se distribuyan en todos los condados. Más recientemente, comenzamos a desplegar los equipos del Laboratorio de Vigilancia de Enfermedades Portátiles en Delaware. Los kits se usarán para monitorear los puntos calientes dentro del estado.
El Instituto Butantan suministra el 90% del antivirus y el 65% de todas las vacunas al sistema de salud pública brasileño. De los 170 millones de dosis de vacunas dispensadas anualmente por el programa de inmunización brasileño, el Instituto Butantan produce 100 millones de unidades. En particular, fabrican el 100% de las dosis de la vacuna contra la gripe que utiliza el Ministerio de Salud. Actualmente, el más importante fabricante de vacunas contra la gripe en el hemisferio sur, el Instituto Butantan ya está procesando muestras de COVID-19 y coordinará una red de 38 laboratorios en el área de São Paulo.
Los científicos del NIAID y los becarios están bien posicionados para desarrollar rápidamente los diagnósticos, terapias y vacunas de COVID-19. Estos proyectos incluyen la realización de investigaciones básicas para comprender cómo el virus infecta las células y causa la enfermedad, y qué intervenciones pueden prevenir y detener la propagación de la enfermedad.
De hecho, a las dos semanas del descubrimiento de COVID-19, los investigadores del NIAID habían determinado cómo el virus entra en las células. Y en el plazo de dos meses los sitios habían comenzado la fase 1 de los ensayos de un tratamiento (remdesivir) y una vacuna (mRNA-1273).
LabWare ha iniciado un proyecto con PT Genomik Solidaritas Indonesia (GSI), un grupo de laboratorios clínicos que serán gestionados y financiados por Indika Energy. Se ha desarrollado un nuevo laboratorio dentro de la GSI para hacer las pruebas de PCR de COVID-19 para Indonesia.
El laboratorio, cuando esté en pleno funcionamiento, realizará hasta 10. 000 muestras por día. La Solución de Salud Clínica (CHS) de LabWare ya está instalada y funcionando en los instrumentos ExiPrep de GSI.
El equipo de VIH del Laboratorio Nacional de Los Álamos está desplegando ahora sus conocimientos especializados en bases de datos genéticos y bioinformática contra el nuevo virus coronavirus SARS-CoV-2 mediante el desarrollo de un enfoque de respuesta de células T, el seguimiento del origen del patógeno y el desarrollo de una sólida reserva de bioinformática.
